WW International Set to Exceed Q1 Fiscal 2024 Subscriber Guidance
Friday, 15 March 2024, 06:53
WW International Surpassing Q1 Guidance
WW International (WW) is set to exceed Q1 fiscal 2024 guidance for clinical subscribers, leading to a 2.1% pre-market stock price increase.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.